ARCA biopharma, Inc. (NASDAQ: ABIO) and Oruka Therapeutics have announced a definitive agreement to merge in an all-stock transaction, poised to reshape the chronic skin disease treatment landscape. The new entity, retaining the name Oruka Therapeutics, Inc., will focus on advancing a pipeline of potentially best-in-class biologics, including ORKA-001 and ORKA-002, targeting IL-23p19 and IL-17A/F…
All posts tagged merger agreement
Fronline Ltd. and Euronav NV sign definitive merger agreement
ANTWERP, BELGIUM: Frontline Ltd. (NYSE: FRO ) and Euronav NV (NYSE: EURN ) have entered into a definitive Combination Agreement for a stock-for-stock combination based on an exchange ratio of 1.45 Frontline-shares for every 1.0 Euronav-share. The agreement memorialises the principal aspects of the previously announced term sheet that was signed on 7 April 2022.…